GR3001443T3 - Unsaturated phosphonic acids and derivatives - Google Patents

Unsaturated phosphonic acids and derivatives

Info

Publication number
GR3001443T3
GR3001443T3 GR90401113T GR900401113T GR3001443T3 GR 3001443 T3 GR3001443 T3 GR 3001443T3 GR 90401113 T GR90401113 T GR 90401113T GR 900401113 T GR900401113 T GR 900401113T GR 3001443 T3 GR3001443 T3 GR 3001443T3
Authority
GR
Greece
Prior art keywords
carbon
carboxyl
derivatives
compounds
membered ring
Prior art date
Application number
GR90401113T
Other languages
English (en)
Inventor
Alan J Hutchison
Kenneth R Shaw
Josef A Schneider
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of GR3001443T3 publication Critical patent/GR3001443T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Quinoline Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dental Preparations (AREA)
GR90401113T 1986-11-21 1991-02-07 Unsaturated phosphonic acids and derivatives GR3001443T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93370286A 1986-11-21 1986-11-21

Publications (1)

Publication Number Publication Date
GR3001443T3 true GR3001443T3 (en) 1992-09-25

Family

ID=25464377

Family Applications (1)

Application Number Title Priority Date Filing Date
GR90401113T GR3001443T3 (en) 1986-11-21 1991-02-07 Unsaturated phosphonic acids and derivatives

Country Status (21)

Country Link
EP (1) EP0275820B1 (el)
JP (1) JPH0686470B2 (el)
KR (1) KR880006195A (el)
AT (1) ATE60776T1 (el)
AU (1) AU610841B2 (el)
CA (1) CA1312608C (el)
DD (1) DD273837A5 (el)
DE (1) DE3768000D1 (el)
DK (1) DK609487A (el)
ES (1) ES2031927T3 (el)
FI (1) FI86638C (el)
GR (1) GR3001443T3 (el)
HU (1) HU199857B (el)
IE (1) IE60534B1 (el)
IL (1) IL84492A0 (el)
MX (1) MX9437A (el)
NO (1) NO170853C (el)
NZ (1) NZ222607A (el)
PH (1) PH25465A (el)
PT (1) PT86168B (el)
ZA (1) ZA878699B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
CA2000901A1 (en) * 1988-10-21 1990-04-21 Alexis A. Cordi Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
EP0424179A3 (en) * 1989-10-20 1991-12-27 John William Olney Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5194430A (en) * 1990-05-17 1993-03-16 Merrell Dow Pharmaceuticals Inc. Heterocyclic-nmda antagonists
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
JP4380803B2 (ja) 1997-06-12 2009-12-09 アベンテイス・フアルマ・リミテツド イミダゾリル−環式アセタール
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2104079B (en) * 1981-08-14 1985-08-21 London Polytech New aminoacid isomers, their production and their medicinal use
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives

Also Published As

Publication number Publication date
EP0275820A3 (en) 1988-08-03
MX9437A (es) 1994-01-31
NO874854D0 (no) 1987-11-20
NZ222607A (en) 1990-10-26
EP0275820A2 (de) 1988-07-27
HUT46331A (en) 1988-10-28
FI86638C (fi) 1992-09-25
JPH0686470B2 (ja) 1994-11-02
DK609487A (da) 1988-05-22
DE3768000D1 (de) 1991-03-14
PT86168A (en) 1987-12-01
KR880006195A (ko) 1988-07-22
FI875097A0 (fi) 1987-11-18
AU610841B2 (en) 1991-05-30
NO874854L (no) 1988-05-24
DD273837A5 (de) 1989-11-29
IL84492A0 (en) 1988-04-29
NO170853C (no) 1992-12-16
HU199857B (en) 1990-03-28
NO170853B (no) 1992-09-07
JPH01135791A (ja) 1989-05-29
ATE60776T1 (de) 1991-02-15
IE60534B1 (en) 1994-07-27
DK609487D0 (da) 1987-11-20
PT86168B (pt) 1990-08-31
EP0275820B1 (de) 1991-02-06
PH25465A (en) 1991-07-01
FI86638B (fi) 1992-06-15
ES2031927T3 (es) 1993-01-01
IE873149L (en) 1988-05-21
FI875097A (fi) 1988-05-22
ZA878699B (en) 1988-05-23
AU8145587A (en) 1988-05-26
CA1312608C (en) 1993-01-12

Similar Documents

Publication Publication Date Title
PT82626A (en) Process for preparing ceryain phosphonil acids and derivatives thereof
EP0275820A3 (en) Unsaturated phosphonic acids and derivatives
FI881892A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
SE8200570L (sv) Tiazolidinderivat med farmakologisk aktivitet samt forfarande for framstellning derav
ES543301A0 (es) Cefalosporinas
ES2076369T3 (es) Procedimiento para la separacion de racematos de esteres de acidos 4-aril-2-oxo-pirrolidina-3-carboxilicos.
ES2053868T3 (es) 3-aminosidnoniminas substituidas, procedimientos para su obtencion y su empleo.
ES2000369A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
DK161090A (da) Nyt topikalt praeparat til behandling af alopeci